CHWY vs WOOF vs BARK

For growth investors, Chewy, Inc.

(CHWY) is the stronger pick with 6. 4% revenue growth year-over-year, versus -2. 5% for Petco Health and Wellness Company, Inc. (WOOF). Chewy, Inc. (CHWY) offers the better valuation at 27. 0x trailing P/E (28. 1x forward), making it the more compelling value choice. Analysts rate Chewy, Inc. (CHWY) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Chewy, Inc.

(CHWY) is the cheapest at 27. 0x versus Petco Health and Wellness Company, Inc. at 86. 4x. On forward P/E, Petco Health and Wellness Company, Inc. is actually cheaper at 18. 7x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Chewy, Inc.

(CHWY) delivered a total return of -65. 6%, compared to -95. 6% for BARK, Inc. (BARK). Over 10 years, the gap is even starker: CHWY returned -29. 7% versus BARK's -96. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Chewy, Inc.

(CHWY) is the lower-risk stock at 0. 70β versus BARK, Inc. 's 1. 96β — meaning BARK is approximately 178% more volatile than CHWY relative to the S&P 500. On balance sheet safety, BARK, Inc. (BARK) carries a lower debt/equity ratio of 86% versus 192% for Chewy, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Chewy, Inc.

(CHWY) is pulling ahead at 6. 4% versus -2. 5% for Petco Health and Wellness Company, Inc. (WOOF). On earnings-per-share growth, the picture is similar: Chewy, Inc. grew EPS 893. 4% year-over-year, compared to 9. 5% for BARK, Inc.. Over a 3-year CAGR, CHWY leads at 9. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Chewy, Inc.

(CHWY) is the more profitable company, earning 3. 3% net margin versus -6. 8% for BARK, Inc. — meaning it keeps 3. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WOOF leads at 2. 0% versus -7. 3% for BARK. At the gross margin level — before operating expenses — BARK leads at 62. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Petco Health and Wellness Company, Inc.

(WOOF) trades at 18. 7x forward P/E versus 28. 1x for Chewy, Inc. — 9. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BARK: 234. 8% to $30. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Chewy, Inc.

(CHWY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70)). BARK, Inc. (BARK) carries a higher beta of 1. 96 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CHWY: -29. 7%, BARK: -96. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.